Message from EAI President regarding COVID-19
EAI banner

Call for Papers

EAI is actively monitoring the COVID-19 situation to ensure the safety, comfort and quality of experience
for attendees
and a successful course of the event.

EAI is committed to holding the conference in 2020 and Accepted Authors who are unable to attend the event in person will be given
an option to present their submission online. In case the situation prevents the event from taking place in its original location,
it will be held fully in an interactive, live online setting. Find out what EAI conference live streams look like and discover unique benefits
that online participation brings you: Learn more

Accepted Authors will be notified about the final decision regarding the conference setting before the Camera-ready deadline.

Scope

Artificial intelligence has undergone enormous developments in recent years and is rapidly finding its way into medicine. AI is becoming relevant for all areas, from prevention to diagnostics and therapy, rehabilitation and care. First clinical applications exist already, but there are still many research questions to be solved for a broad deployment. In view of the COVID 19 pandemic, AI has gained enormous additional importance, as there are a number of promising approaches for combating this worldwide crisis.

Submit paper

Welcome to the EAI Community

Let the EAI Community help you build your career with collaborative research, objective evaluation, and fair recognition:

  • Get more visibility for your paper and receive a fair review with Community Review,
  • Earn credits regardless of your paper’s acceptance and increase your EAI Index for new membership ranks and global recognition,
  • Find out if your research resonates – get real-time evaluation of your presentation on-site via EAI Compass.

Topics

In view of the current situation around COVID-19, the organizers would like to use the chance arising from this crisis and make MedAI 2020 an important forum for the discussion of AI approaches to fight the pandemic.

We therefore invite researchers and users for paper submissions (8 -15 pages) that strengthen the continuing effort to bring AI into medical application, with a specific emphasis on approaches to fight COVID-19. We expect submissions from all areas of Artificial Intelligence in medicine, in particular but not limited to:

  • Medical data processing and analysis
  • Medical imaging
  • Health data mining and modelling
  • Computer-Aided Diagnosis
  • Precision Medicine
  • Medical device control
  • Health monitoring
  • Clinical decision making
  • Medical robotics
  • Ambient assisted living
  • Telemedicine and e-health
  • Faster drug development
  • Smart care
  • Hospital organization
  • Tracing apps
  • Big data processing
  • Privacy and security issues

Publication

All accepted and presented papers will be submitted for publishing by Springer and made available through SpringerLink Digital Library.

Proceedings will be submitted for inclusion in leading indexing services, Ei Compendex, ISI Web of Science, Scopus, CrossRef, Google Scholar, DBLP, as well as EAI’s own EU Digital Library (EUDL).

All accepted authors are eligible to submit an extended version in a fast track of:

Additional publication opportunities:

Community Review

Community Review is a service offered to Program Committees and submitting Authors of all EAI conferences designed to improve the speed and the quality of the review process.

Abstracts of all authors who opt in to Community Review during submission will be published and available for Bidding here.

Learn more about the Community Review process

Paper submission

Papers should be submitted through EAI ‘Confy+‘ system, and have to comply with the Springer format (see Author’s kit section).

Important dates

Loading important dates.
EAI Institutional Members